<DOC>
	<DOCNO>NCT00152087</DOCNO>
	<brief_summary>Surgical resection affect liver offer best chance disease-free survival patient Hepatoma ( HCC ) . Unfortunately , hepatoma patient present disease multi-focal thus resectable . Fewer 15 % HCC patient resectable . The objective treatment TheraSphere selectively administer dose radioactive material directly neoplastic tissue liver . Systemic therapy largely ineffective .</brief_summary>
	<brief_title>A Non-Randomized Study Internal Radiation Therapy Liver Patients With Primary Liver Cancer Whom Surgery Not Possible .</brief_title>
	<detailed_description>Protocol Objectives include : - Determine proportion patient HCC treatment plan complete - Evaluate response therapy - Evaluate toxicity adverse experience associate TheraSphere treatment - Evaluate survival time</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Over 18 year age sex , race Histological proof HCC Able give Informed Consent ECOG performance equal le 2 Life expectancy equal great 3 month Non pregnant acceptable contraception premenopausal woman Greater 4 week since prior radiation therapy surgery 1 month post chemotherapy Serum Bilirubin &lt; 2.0 Acceptable white blood count Comorbid disease would place patient undue risk . Preexisting diarrhea/illness Pregnant Fail preliminary MAA testing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Liver cancer</keyword>
	<keyword>Brachytherapy</keyword>
</DOC>